HCC Risk Prediction Model - For Patients Under Treatment

1. Model for Initial Treatment Patients 2. Model for Patients Under Treatment

HCC Risk Prediction Model - For Patients Under Treatment

Gender

Male Female

Age (years)

30-34 35-39

40-44 45-49

50-54 55-59

60-64

Alanine Aminotransferase (ALT, U/L)

<15 15-44

≥45

e Antigen (HBeAg)

Negative Positive

Liver Stiffness (LS value, kPa)

<8.0 8.0-13.0

>13.0

Note: This tool is applicable to hepatitis B patients with HBV DNA <20 IU/mL after antiviral treatment.

Due to the data you provided, this test result is for reference only and does not represent any medical advice. Specific diagnosis and treatment should be based on professional medical advice.

References:

1. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients

2. Validation of Hepatitis B Virus–Related Hepatocellular Carcinoma Prediction Models in the Era of Antiviral Therapy (Supplementary)

Favorite